Literature DB >> 33000874

Bi-objective optimization of catheter positions for high-dose-rate prostate brachytherapy.

Marjolein C van der Meer1, Peter A N Bosman2, Yury Niatsetski3, Tanja Alderliesten4, Niek van Wieringen1, Bradley R Pieters1, Arjan Bel1.   

Abstract

PURPOSE: Bi-objective simultaneous optimization of catheter positions and dwell times for high-dose-rate (HDR) prostate brachytherapy, based directly on dose-volume indices, has shown promising results. However, optimization with the state-of-the-art evolutionary algorithm MO-RV-GOMEA so far required several hours of runtime, and resulting catheter positions were not always clinically feasible. The aim of this study is to extend the optimization model and apply GPU parallelization to achieve clinically acceptable computation times. The resulting optimization procedure is compared with a previously introduced method based solely on geometric criteria, the adapted Centroidal Voronoi Tessellations (CVT) algorithm.
METHODS: Bi-objective simultaneous optimization was performed with a GPU-parallelized version of MO-RV-GOMEA. This optimization of catheter positions and dwell times was retrospectively applied to the data of 26 patients previously treated with HDR prostate brachytherapy for 8-16 catheters (steps of 2). Optimization of catheter positions using CVT was performed in seconds, after which optimization of only the dwell times using MO-RV-GOMEA was performed in 1 min.
RESULTS: Simultaneous optimization of catheter positions and dwell times using MO-RV-GOMEA was performed in 5 min. For 16 down to 8 catheters (steps of 2), MO-RV-GOMEA found plans satisfying the planning-aims for 20, 20, 18, 14, and 11 out of the 26 patients, respectively. CVT achieved this for 19, 17, 13, 9, and 2 patients, respectively. The P-value for the difference between MO-RV-GOMEA and CVT was 0.023 for 16 catheters, 0.005 for 14 catheters, and <0.001 for 12, 10, and 8 catheters.
CONCLUSIONS: With bi-objective simultaneous optimization on a GPU, high-quality catheter positions can now be obtained within 5 min, which is clinically acceptable, but slower than CVT. For 16 catheters, the difference between MO-RV-GOMEA and CVT is clinically irrelevant. For 14 catheters and less, MO-RV-GOMEA outperforms CVT in finding plans satisfying all planning-aims.
© 2020 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  HDR brachytherapy; bi-objective optimization; catheter positions; prostate neoplasms; treatment planning

Mesh:

Year:  2020        PMID: 33000874      PMCID: PMC7821293          DOI: 10.1002/mp.14505

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  20 in total

1.  Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function.

Authors:  E Lessard; J Pouliot
Journal:  Med Phys       Date:  2001-05       Impact factor: 4.071

2.  A hybrid evolutionary algorithm for multi-objective anatomy-based dose optimization in high-dose-rate brachytherapy.

Authors:  M Lahanas; D Baltas; N Zamboglou
Journal:  Phys Med Biol       Date:  2003-02-07       Impact factor: 3.609

3.  Multiobjective anatomy-based dose optimization for HDR-brachytherapy with constraint free deterministic algorithms.

Authors:  N Milickovic; M Lahanas; M Papagiannopoulo; N Zamboglou; D Baltas
Journal:  Phys Med Biol       Date:  2002-07-07       Impact factor: 3.609

4.  Comparison of dose and catheter optimization algorithms in prostate high-dose-rate brachytherapy.

Authors:  Eric Poulin; Nicolas Varfalvy; Sylviane Aubin; Luc Beaulieu
Journal:  Brachytherapy       Date:  2015-11-07       Impact factor: 2.362

5.  High-dose-rate prostate brachytherapy inverse planning on dose-volume criteria by simulated annealing.

Authors:  T M Deist; B L Gorissen
Journal:  Phys Med Biol       Date:  2016-01-13       Impact factor: 3.609

6.  Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source.

Authors:  G M Daskalov; E Löffler; J F Williamson
Journal:  Med Phys       Date:  1998-11       Impact factor: 4.071

7.  IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices.

Authors:  Timmy Siauw; Adam Cunha; Alper Atamtürk; I-Chow Hsu; Jean Pouliot; Ken Goldberg
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

8.  Mixed integer programming improves comprehensibility and plan quality in inverse optimization of prostate HDR brachytherapy.

Authors:  Bram L Gorissen; Dick den Hertog; Aswin L Hoffmann
Journal:  Phys Med Biol       Date:  2013-01-31       Impact factor: 3.609

9.  A GPU-based multi-criteria optimization algorithm for HDR brachytherapy.

Authors:  Cédric Bélanger; Songye Cui; Yunzhi Ma; Philippe Després; J Adam M Cunha; Luc Beaulieu
Journal:  Phys Med Biol       Date:  2019-05-08       Impact factor: 3.609

10.  A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.

Authors:  Carlos Vargas; Michel Ghilezan; Mitchell Hollander; Gary Gustafson; Howard Korman; Jose Gonzalez; Alvaro Martinez
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.